Cardiovascular and renal outcomes according to KDIGO stages of chronic kidney disease in the Spanish population: Insights from real-world evidence Rafael Santamaria; Carlos Escobar; Unai Aranda; Beatriz Palacios; Margarita Capel; Ignacio Hernández; Ana Cebrián; Roberto Alcázar; Manuel Gorostidi;

Safety and efficacy of sodium-glucose co-transporter-2 inhibitors and aldosterone inhibitors combinations in chronic kidney disease: A systematic review and meta-analysis Ahmed W. Hageen; Reem Sayad; Alyaa Khaled Abdelmonem; Katia Latifa; Lina Musallam; Moustafa Abouelkheir; Sherif Mira; Ahmed Awad; Ahmed Afsa; Waleed Nassar; Gehad El Ashal; Mohamed Elmasry; Eshak I. Bahbah;

Estudio Delphi multidisciplinar sobre riesgo residual en pacientes con enfermedad renal crónica y diabetes mellitus tipo 2 Alberto Ortiz; Ana Cebrián; Alfonso Soto; Andrés Reyes; Jose Luis Górriz;